Article
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
14 Aug 2017
Abstract excerpt
Middle East respiratory syndrome coronavirus (MERS-CoV) is a lineage C betacoronavirus that since its emergence in 2012 has caused outbreaks in human populations with case-fatality rates of ∼36%. As in other coronaviruses, the spike (S) glycoprotein of MERS-CoV mediates receptor recognition and membrane fusion and is the primary target of the humoral immune response during infection. Here we use structure-based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
